Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
233K
-
Shares change
-
-65.9K
-
Total reported value, excl. options
-
$2.11M
-
Value change
-
-$353K
-
Put/Call ratio
-
0.31
-
Number of buys
-
1
-
Number of sells
-
-4
-
Price
-
$7.26
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q3 2021
11 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q3 2021.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 233K shares
of 98M outstanding shares and own 0.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (217K shares), Cutler Group LP (15.5K shares), BANK OF AMERICA CORP /DE/ (382 shares), Charter Oak Capital Management, LLC (150 shares), UBS Group AG (0 shares), XTX Topco Ltd (0 shares), ACADIAN ASSET MANAGEMENT LLC (0 shares), Cutler Group LP (64.9K shares), HAP Trading, LLC (20.4K shares), and Belvedere Trading LLC (10.7K shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.